Overweight and Obesity in Saudi Patients with Schizophrenia Affects Cholesterol Concentration and Some Immune System Cells
Asian Journal of Immunology,
Introduction: Schizophrenia (SZ), a prevalent and highly debilitating mental disease, is associated with high rates of overweight and obesity and effects on different systems of the body including the immune system. There are very few studies worldwide on weight measured by the body mass index (BMI) in patients with SZ and its effect on blood parameters, while there are no such studies in Saudi Arabia.
Aims: This study is the first to determine the effects of weight, measured by the BMI, on the differential complete blood count in patients with SZ. Additionally, the serum lipid profile was determined.
Methodology: Blood samples were collected from 45 randomly chosen male inpatients with SZ with an age range of 28-47 years and a mean age of 37 years.
Results: BMI categorization of the patients showed that 6.7% were underweight, 53.3% were healthy, 24.4% were overweight, and 15.6% were obese. Compared with the healthy BMI, significantly lower cholesterol levels and neutrophil counts were found for the overweight BMI group, while significantly higher cholesterol levels and monocyte percents were found for the obese BMI group.
Conclusion: Most subjects had a healthy BMI while overweight and obese subjects showed effects on cholesterol levels and counts of innate immune system cells.
- immune system
- complete blood count
- lipid profile
- body mass index
- saudi male
How to Cite
King Salman Center for Disability Research. Saudi National Mental Health Survey: Technical Report; 2019. Available:http://www.healthandstress.org.sa/.
American Psychiatric Association. What Is Schizophrenia?; 2020. Available:https://www.psychiatry.org/patients-families/schizophrenia/what-is-schizophrenia
World Health Organization. Risks to mental health: an overview of vulnerabilities and risk factors; 2012.
Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychological Medicine. 1999;29(3):697-701.
Coodin S. Body mass index in persons with schizophrenia. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 2001;46(6):549–555.
Strassnig M, Brar JS, Ganguli R. Body mass index and quality of life in community-dwelling patients with schizophrenia. Schizophrenia Research. 2003;62(1-2):73–76.
Guo X, Zhang Z, Wei Q, Lv H, Wu R, Zhao J. The relationship between obesity and neurocognitive function in Chinese patients with schizophrenia. BMC psychiatry. 2013; 13:109.
Chouinard VA, Pingali SM, Chouinard G, Henderson DC, Mallya SG, Cypess AM, et al. Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders. Psychiatry Research. 2016;237:304–310.
Kamel A, Abuhegazy H, Ismail A, Sherra K, Ramadan M, Mekky A, et al. The prevalence of obesity in a sample of Egyptian psychiatric patients. Egyptian Journal of Psychiatry. 2016;37:157– 165.
Cameron I, Hamilton R, Fernie G, MacGillivray S. Obesity in individuals with schizophrenia: A case-controlled study in Scotland. BJPsych Open. 2017;3(5):254-256.
Boozalis T, Devaraj S, Okusaga OO. Correlations between Body Mass Index, Plasma High-Sensitivity C-Reactive Protein and Lipids in Patients with Schizophrenia. The Psychiatric Quarterly. 2019;90(1):101–110.
Bourassa KA, Postolache TT, Dagdag A, Fuchs D, Okusaga OO. Plasma soluble P-selectin correlates with triglycerides and nitrite in overweight/obese patients with schizophrenia. Pteridines. 2020;31(1):61–67.
Bak M, Fransen A, Janssen J, van Os J, Drukker M. Almost all antipsychotics result in weight gain: A meta-analysis. PloS One. 2014;9(4):e94112.
Annamalai A, Kosir U, Tek C. Prevalence of obesity and diabetes in patients with SZ. World journal of diabetes. 2017;8(8):390–396.
World Obesity Federation. Ranking (% obesity by country); 2016. Available:https://data.worldobesity.org/rankings/?age=a&sex=m
World Health Organisation. Diabetes countery profiles; 2016. Available:https://www.who.int/diabetes/country-profiles/sau_en.pdf
Malnick SDH, Knobler H. The medical complications of obesity, QJM: An International Journal of Medicine. 2006;99(9):565–579.
World Health Organisation. Obesity and Overweight Fact Sheet; 2016. Available:http://www.who.int/mediacentre/factsheets/fs311/en/
Bhatti MS, Akbri MZ, Shakoor M. Lipid profile in obesity. Journal of Ayub Medical College, Abbottabad: JAMC. 2001;13(1):31–33.
Njelekela MA, Negishi H, Nara Y, Sato T, Tomohiro M, Kuga S, et al. Obesity and lipid profiles in middle aged men and women in Tanzania. East African Medical Journal. 2002;79(2):58–64.
Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: Findings from the National Health and Nutrition Examination Survey, 1999 to 2004. Journal of the American College of Surgeons. 2008;207(6):928–934.
Shabana Shahid SU, Sarwar S. The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects. Lipids Health Dis. 2020;19(73).
Dasgupta A, Wahed A. Lipid Metabolism and Disorders. Clinical Chemistry, Immunology and Laboratory Quality Control. 2014;85–105.
Perica,MM. and Delaš, I. Essential Fatty Acids and Psychiatric Disorders. Nutrition in Clinical Practice. 2011;26(4):409–425.
Solberg DK, Bentsen H, Refsum H, Andreassen OA. Lipid profiles in schizophrenia associated with clinical traits: a five-year follow-up study. BMC psychiatry. 2016;16(1):299.
Gohar SM, Dieset I, Steen NE, Mørch RH, Vedal T, Reponen EJ, et al. Association between leptin levels and severity of suicidal behaviour in schizophrenia spectrum disorders. Acta psychiatrica Scandinavica. 2019;139(5):464–471.
Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: The Women's Health Initiative Observational Study. Archives of Internal Medicine. 2005;165(5):500–508.
Mahassni SH, Bashanfar NO. High Levels of Inflammatory Adipokines and C-reactive protein, and Minimal Changes in Immune Cells in Overweight and Obese Saudi Female University Students. Int. J. Pharm. Res. Allied Sci. 2019;8(1):171-183.
Mahassni SH. Overweight and Obesity and the Immune System, Lipids and C-reactive Protein in Young and Middle-aged Saudi Female University Worker. J Biochem Tech. 2020;11(1):49-56.
Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. The Journal of Clinical Investigation. 2003;112(12):1785–1788.
Opal SM, DePalo VA. Anti-Inflammatory Cytokines. CHEST. 2000;117(4):1162-1172.
Schmidt FM, Weschenfelder J, Sander C, Minkwitz J, Thormann J, Chittka T, et al. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PloS One. 2015; 10(3):e0121971.
Parkin J, Cohen B. An overview of the immune system. THE LANCET. 2001;357: 1777–89.
Rao DS. Overview and Compartmentalization of the Immune System. Hematology. 2018;199- 209.
Anderson HL, Brodsky IE, Mangalmurti NS. The Evolving Erythrocyte: Red Blood Cells as Modulators of Innate Immunity. Journal of immunology (Baltimore, Md.: 1950). 2018;201(5):1343–1351.
Hotz MJ, Qing D, Shashaty M, Zhang P, Faust H, Sondheimer N, et al. Red Blood Cells Homeostatically Bind Mitochondrial DNA through TLR9 to Maintain Quiescence and to Prevent Lung Injury. American journal of respiratory and critical care medicine. 2018;197(4):470–480.
Ali RA, Wuescher LM, Worth RG. Platelets: essential components of the immune system. Current trends in Immunology. 2015;16:65–78.
Holinstat M. Normal platelet function. Cancer Metastasis Reviews. 2017;36(2):195–198.
Wagner DD, Burger PC. Platelets in inflammation and thrombosis. ArteriosclerThrombVasc Biol. 2003;23:2131–2137.
Wasti AZ, Zahid S, Ahmed N. Antipsychotic Drugs Induced Iron Deficiency Anemia in Schizophrenic Patients. International Journal of Advanced Research. 2013;1(10):111-118.
Fan X, Liu EY, Freudenreich O, Park JH, Liu D, Wang J, et al. Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia. Schizophrenia Research. 2010;118(1-3):211–217.
Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis. 2003;169(2):203–214.
Garcia-Rizo C. Casanovas, M., Fernandez-Egea, E., Oliveira, C., Meseguer, A., Cabrera, B., et al. Blood cell count in antipsychotic-naive patients with non-affective psychosis. Early Intervention in Psychiatry. 2019;13(1):95–100.
Semiz M, Yildirim O, Canan F, Demir S, Hasbek E, Tuman TC, et al. Elevated neutrophil/lymphocyte ratio in patients with schizophrenia. PsychiatriaDanubina. 2014;26(3):220–225.
Zahorec R. Ratio of neutrophil to lymphocyte counts rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102:5-14.
Özdin S, Sarisoy G, Böke Ö. A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder patients – a retrospective file review. Nordic Journal of Psychiatry. 2017;71(7): 509–512.
Ighoroje M, Ogundele A, Abayomi O. Obesity and Pattern of Use of Antipsychotic Agents among Outpatients with Schizophrenia in Nigeria. International Journal of Clinical Psychiatry. 2017;5(2): 32-38.
Kitabayashi Y, Narumoto J, Kitabayashi M, Fukui K. Body Mass Index among Japanese Inpatients with Schizophrenia. The International Journal of Psychiatry in Medicine. 2006;36(1):93–102.
Inamura Y, Sagae T, Nakamachi K, Murayama N. Body mass index of inpatients with schizophrenia in Japan. International Journal of Psychiatry in Medicine. 2012;44(2):171–181.
Marthoenis M, Aichberger M, Puteh I, Schouler-Ocak M. Low rate of obesity among psychiatric inpatients in Indonesia. The International Journal of Psychiatry in Medicine. 2014;48(3):175-83.
Charles LE, Fekedulegn D, McCall T, Burchfiel CM, Andrew ME, Violanti JM. Obesity, white blood cell counts, and platelet counts among police officers. Obesity (Silver Spring, Md.). 2007; 15(11):2846–2854.
Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C. The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis. 2005; 183(2):308–315.
Alrubai A, Majid SH, Alrubaie R, Kadhim, F. Effects of Body Mass Index (BMI) on complete blood count parameters. Prensaméd. Argent. 2019;105(5):164- 171.
Kullo IJ, Hensrud DD, Allison TG. Comparison of numbers of circulating blood monocytes in men grouped by body mass index (<25, 25 to <30, > or =30). The American Journal of Cardiology. 2002; 89(12):1441–1443.
Friedrich K, Sommer M, Strobel S, Thrum S, Blüher M, Wagner U, et al. Perturbation of the Monocyte Compartment in Human Obesity. Frontiers in Immunology. 2019;10:1874.
Porwit A, McCullough J, Erber WN. Blood and Bone Marrow Pathology. 2nd ed., (Churchill Livingstone). 2011;257.
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Jr Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation. 2003;112(12):1796–1808.
Nagareddy PR, Kraakman M, Masters SL, Stirzaker RA, Gorman DJ, Grant RW, et al. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metabolism. 2014;19(5):821–835.
Korkmaz S, Yıldız S, Korucu T, Gundogan B, Sunbul ZE, Korkmaz H, et al. Frequency of anemia in chronic psychiatry patients. Neuropsychiatric Disease and Treatment. 2015;11:2737–2741.
Samocha-Bonet D, Justo D, Rogowski O, Saar N, Abu-Abeid S, Shenkerman G, et al. Platelet counts and platelet activation markers in obese subjects. Mediators of Inflammation. 2008;834153.
Koca TT. Does obesity cause chronic inflammation? The association between complete blood parameters with body mass index and fasting glucose. Pakistan Journal of Medical Sciences. 2017;33(1):65–69.
Gao K, Zhu W, Liu W, Ma D, Li H, Yu W, et al. The predictive role of monocyte-to-lymphocyte ratio in osteoporosis patient. Medicine. 2019;98(34):e16793.
Abstract View: 78 times
PDF Download: 26 times